Metraipolis › archive › dc_04853a769a2d

Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials — Europe PMC PMID:41346601

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41346601
DOI
10.3389/fimmu.2025.1692336
License (as archived)
solo-consultazione
Archived
2026-11-08T10:58:10.667Z
SHA-256 of the archived text
0891b90330bb60a3981176ac30f7c31b052b02106738ae8c4d1c95ac93e810d2
Stable URL of this page
https://metraipolis.com/documento/dc_04853a769a2d

How to cite

Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials — Europe PMC PMID:41346601 — Europe PMC (en), https://europepmc.org/article/MED/41346601 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04853a769a2d (Metraipolis archive dc_04853a769a2d, sha256 0891b90330bb60a3981176ac30f7c31b052b02106738ae8c4d1c95ac93e810d2)
BibTeX
@misc{dc04853a769a2d,
  title = {Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials — Europe PMC PMID:41346601},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41346601},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04853a769a2d; sha256 0891b90330bb60a3981176ac30f7c31b052b02106738ae8c4d1c95ac93e810d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41346601. Agents can read the archived copy with the MCP tool read_document.